249
Participants
Start Date
September 21, 2020
Primary Completion Date
July 2, 2021
Study Completion Date
December 6, 2021
EDP1815
EDP1815 is an orally administered, pharmaceutical preparation of a single strain of bacteria
Placebo
Placebo oral capsule
Synexus Budapest - Magyarország Egészségügyi Szolgáltató Kft, Budapest
Synexus Zalaegerszeg Magyarország Egészségügyi Kft, Zalaegerszeg
Synexus Clinical Research US, Inc. - Anderson, Anderson
Synexus Clinical Research US, Inc. - The Villages, The Villages
Synexus Clinical Research US, Inc. - Orlando, Orlando
ForCare Clinical Research, Tampa
Synexus Clinical Research US, Inc. - St. Petersburg, St. Petersburg
Synexus Clinical Research US, Inc. - Cincinnati, Cincinnati
Synexus Clinical Research US, Inc. - Santa Rosa, Santa Rosa
Oregon Medical Research Center PC, Portland
Synexus - Poznan, Poznan
Synexus - Wroclaw, Wroclaw
Synexus - Gdansk, Gdansk
Synexus - Gdynia, Gdynia
Synexus - Czestochowa, Częstochowa
Synexus - Katowice, Katowice
Synexus - Lodz, Lodz
Synexus - Warszawa, Warsaw
Synexus - Thames Valley Clinical Research Centre, Reading
MAC Clinical Research, Blackpool
Synexus - Lancashire Clinical Research Centre, Chorley
Synexus - Merseyside Clinical Research Centre, Waterloo
Medicine Evaluation Unit, Wythenshawe
MAC Clinical Research, Stockton-on-Tees
MAC Clinical Research, Cannock
Synexus - Wales Clinical Research Centre, Cardiff
MAC Clinical Research, Leeds
Synexus - Scotland Clinical Research Centre, Glasgow
Synexus - Manchester Clinical Research Centre, Manchester
Lead Sponsor
Evelo Biosciences, Inc.
INDUSTRY